Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit

Synapse

Volumn 67, Issue 5, 2013, Pages 245-257

  North, Ashley ^a   Swant, Jarod ^b   Salvatore, Michael F ^c   Gamble George, Joyonna ^d   Prins, Petra ^d   Butler, Brittany ^b   Mittal, Mukul K ^a   Heltsley, Rebecca ^e   Clark, John T ^a   Khoshbouei, Habibeh ^b,f  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e Aegis Sciences Corporation   (United States)

^f Department of Psychiatry ^*  (United States)

Author keywords

Cognition; Long term potentiation; Neurotoxicity; Psychostimulant; Synaptic transmission

Indexed keywords

METHAMPHETAMINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DRUG WITHDRAWAL; HIPPOCAMPUS; LONG TERM EXPOSURE; LONG TERM POTENTIATION; MEMORY DISORDER; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SHORT TERM MEMORY; SPATIAL MEMORY; WESTERN BLOTTING;

AGE FACTORS; ANIMALS; DOPAMINE AGENTS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MEMORY, SHORT-TERM; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; TIME FACTORS;

EID: 84875532713     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21635     Document Type: Article

References (88)

1. Centers for Disease Control and Prevention (CDC). 2005. Acute public health consequences of methamphetamine laboratories-16 states, January 2000-June 2004. MMWR Morb Mortal Wkly Rep 54:356-359.
2. Aggleton JP, Mishkin M. 1985. Mamillary-body lesions and visual recognition in monkeys. Exp Brain Res 58:190-197.
3. Aggleton JP, Nicol RM, Huston AE, Fairbairn AF. 1988. The performance of amnesic subjects on tests of experimental amnesia in animals: Delayed matching-to-sample and concurrent learning. Neuropsychologia 26:265-272.
4. Akiyama K, Saito A, Shimoda K. 2011. Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients. Am J Addict 20:240-249.
5. Akkerman S, Blokland A, Reneerkens O, van Goethem NP, Bollen E, Gijselaers HJ, Lieben CK, Steinbusch HW, Prickaerts J. 2012. Object recognition testing: methodological considerations on exploration and discrimination measures. Behav Brain Res 232:335-347.
6. Anderson MJ, Jablonski SA, Klimas DB. 2008. Spaced initial stimulus familiarization enhances novelty preference in Long-Evans rats. Behav Processes 78:481-486.
7. Armstrong BD, Noguchi KK. 2004. The neurotoxic effects of 3, 4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: An in-vitro autoradiographic study in rats. Neurotoxicology 25:905-914.
8. Baucum AJ, 2nd, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE. 2004. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. J Neurosci 24:3436-3443.
9. Belcher AM, Feinstein EM, O'Dell SJ, Marshall JF. 2008. Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 33:1453-1463.
10. Belcher AM, O'Dell SJ, Marshall JF. 2005. Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30:2026-2034.
11. Belcher AM, O'Dell SJ, Marshall JF. 2006. A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition. Behav Brain Res 170:167-172.
12. Bell DS. 1973. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 29:35-40.
13. Berlyne DE. 1950. Novelty and curiosity as determinants of exploratory behaviour1. Br J Psychol 41:68-80.
14. Bertaina-Anglade V, Enjuanes E, Morillon D, Drieu la Rochelle C. 2006. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. J Pharmacol Toxicol Methods 54:99-105.
15. Bisagno V, Ferguson D, Luine VN. 2002. Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Res 940:95-101.
16. Boger HA, Middaugh LD, Patrick KS, Ramamoorthy S, Denehy ED, Zhu H, Pacchioni AM, Granholm AC, McGinty JF. 2007. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci 27:8816-8825.
17. Cadet JL. 2001. Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice. Parkinsonism Relat Disord 8:85-90.
18. Cadet JL, Brannock C, Ladenheim B, McCoy MT, Beauvais G, Hodges AB, Lehrmann E, Wood WH, 3rd, Becker KG, Krasnova IN. 2011. Methamphetamine preconditioning causes differential changes in striatal transcriptional responses to large doses of the drug. Dose Response 9:165-181.
19. Cadet JL, Jayanthi S, Deng X. 2005. Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review. Neurotox Res 8:199-206.
20. Cadet JL, Krasnova IN, Jayanthi S, Lyles J. 2007. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 11:183-202.
21. Cesarovic N, Jirkof P, Rettich A, Arras M. 2011. Implantation of radiotelemetry transmitters yielding data on ECG, heart rate, core body temperature and activity in free-moving laboratory mice. J Vis Exp (57).
22. Chang L, Alicata D, Ernst T, Volkow N. 2007. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(Suppl 1):16-32.
23. Del Olmo N, Higuera-Matas A, Miguens M, Garcia-Lecumberri C, Borcel E, Solis JM, Ambrosio E. 2006a. Hippocampal synaptic plasticity and water maze learning in cocaine self-administered rats. Ann NY Acad Sci 1074:427-437.
24. del Olmo N, Miguens M, Higuera-Matas A, Torres I, Garcia-Lecumberri C, Solis JM, Ambrosio E. 2006b. Enhancement of hippocampal long-term potentiation induced by cocaine self-administration is maintained during the extinction of this behavior. Brain Res 1116:120-126.
25. Dere E, Huston JP, De Souza Silva MA. 2005. Integrated memory for objects, places, and temporal order: evidence for episodic-like memory in mice. Neurobiol Learn Mem 84:214-221.
26. Ennaceur A. 2010. One-trial object recognition in rats and mice: Methodological and theoretical issues. Behav Brain Res 215:244-254.
27. Ennaceur A, Delacour J. 1988. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31:47-59.
28. Everitt BJ, Robbins TW. 2005. Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nat Neurosci 8:1481-1489.
29. Ferguson MC, Nayyar T, Deutch AY, Ansah TA. 2010. 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease. Neuropharmacology 59:31-36.
30. French SJ, Hailstone JC, Totterdell S. 2003. Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines. Brain Res 981:160-167.
31. French SJ, Totterdell S. 2003. Individual nucleus accumbens-projection neurons receive both basolateral amygdala and ventral subicular afferents in rats. Neuroscience 119:19-31.
32. Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG. 1998. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci 18:4861-4869.
33. Gasbarri A, Sulli A, Packard MG. 1997. The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog Neuropsychopharmacol Biol Psychiatry 21:1-22.
34. Gonzalez R, Bechara A, Martin EM. 2007. Executive functions among individuals with methamphetamine or alcohol as drugs of choice: Preliminary observations. J Clin Exp Neuropsychol 29:155-159.
35. Guan X, Zhang R, Xu Y, Li S. 2009. Cocaine withdrawal enhances long-term potentiation in rat hippocampus via changing the activity of corticotropin-releasing factor receptor subtype 2. Neuroscience 161:665-670.
36. Hannesson DK, Howland JG, Phillips AG. 2004. Interaction between perirhinal and medial prefrontal cortex is required for temporal order but not recognition memory for objects in rats. J Neurosci 24:4596-4604.
37. Hastrup H, Sen N, Javitch JA. 2003. The human dopamine transporter forms a tetramer in the plasma membrane: Cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs. J Biol Chem 278:45045-45048.
38. Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH. 2006. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology 188:162-170.
39. Hori N, Kadota MT, Watanabe M, Ito Y, Akaike N, Carpenter DO. 2010. Neurotoxic effects of methamphetamine on rat hippocampus pyramidal neurons. Cell Mol Neurobiol 30:849-856.
40. Joksovic P, Mellos N, van Wattum PJ, Chiles C. 2012. "Bath salts"-induced psychosis and serotonin toxicity. J Clin Psychiatry 73:1125.
41. Kart-Teke E, De Souza Silva MA, Huston JP, Dere E. 2006. Wistar rats show episodic-like memory for unique experiences. Neurobiol Learn Mem 85:173-182.
42. Kart-Teke E, Dere E, Brandao ML, Huston JP, De Souza Silva MA. 2007. Reinstatement of episodic-like memory in rats by neurokinin-1 receptor antagonism. Neurobiol Learn Mem 87:324-331.
43. Kauer JA, Malenka RC. 2007. Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-858.
44. Keleta YB, Martinez JL. 2012. Brain circuits of methamphetamine place reinforcement learning: The role of the hippocampus-VTA loop. Brain Behav 2:128-141.
45. Keller CM, Salvatore MF, Pruett BS, Guerin GF, Goeders NE. 2011. Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contingent binge and escalating methamphetamine regimens in the Wistar rat. Psychopharmacology 215:513-526.
46. Kensinger EA, Ullman MT, Corkin S. 2001. Bilateral medial temporal lobe damage does not affect lexical or grammatical processing: evidence from amnesic patient H.M. Hippocampus 11:347-360.
47. Khoshbouei H, Cecchi M, Dove S, Javors M, Morilak DA. 2002. Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav 71:407-417.
48. Krasnova IN, Justinova Z, Ladenheim B, Jayanthi S, McCoy MT, Barnes C, Warner JE, Goldberg SR, Cadet JL. 2010. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS One 5:e8790.
49. Marshall JF, Belcher AM, Feinstein EM, O'Dell SJ. 2007. Methamphetamine-induced neural and cognitive changes in rodents. Addiction 102(Suppl 1):61-69.
50. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J, Ye W, Alexander M, Dannals RF, Wong DF, Ricaurte GA. 2008. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62:91-100.
51. Mitchell JB, Laiacona J. 1998. The medial frontal cortex and temporal memory: tests using spontaneous exploratory behaviour in the rat. Behav Brain Res 97:107-113.
52. Moss S, Sharott A, Goodhead LH, Mitchell SN. 2003. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens. Eur J Pharmacol 460:117-125.
53. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H. 2002. Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn Mem 9:49-57.
54. Nishioku T, Shimazoe T, Yamamoto Y, Nakanishi H, Watanabe S. 1999. Expression of long-term potentiation of the striatum in methamphetamine-sensitized rats. Neurosci Lett 268:81-84.
55. O'Callaghan JP, Miller DB. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741-751.
56. O'Callaghan JP, Sriram K, Miller DB. 2008. Defining "neuroinflammation". Ann NY Acad Sci 1139:318-330.
57. Onaivi ES, Ali SF, Chirwa SS, Zwiller J, Thiriet N, Akinshola BE, Ishiguro H. 2002. Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation. Ann NY Acad Sci 965:28-46.
58. Orikabe L, Yamasue H, Inoue H, Takayanagi Y, Mozue Y, Sudo Y, Ishii T, Itokawa M, Suzuki M, Kurachi M, Okazaki Y, Kasai K. 2011. Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis. Schizophrenia Res 132:183-189.
59. Rasimas JJ. 2012. "Bath salts" and the return of serotonin syndrome. J Clin Psychiatry 73:1126-1127.
60. Ricoy UM, Martinez JL Jr. 2009. Local hippocampal methamphetamine-induced reinforcement. Front Behav Neurosci 3:47.
61. Riddle EL, Kokoshka JM, Wilkins DG, Hanson GR, Fleckenstein AE. 2002. Tolerance to the neurotoxic effects of methamphetamine in young rats. Eur J Pharmacol 435:181-185.
62. Sailasuta N, Abulseoud O, Harris KC, Ross BD. 2010. Glial dysfunction in abstinent methamphetamine abusers. J Cereb Blood Flow Metab 30:950-960.
63. Sambeth A, Riedel WJ, Smits LT, Blokland A. 2007. Cholinergic drugs affect novel object recognition in rats: Relation with hippocampal EEG? Eur J Pharmacol 572:151-159.
64. Scatton B, Simon H, Le Moal M, Bischoff S. 1980. Origin of dopaminergic innervation of the rat hippocampal formation. Neurosci Lett 18:125-131.
65. Schroder N, O'Dell SJ, Marshall JF. 2003. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 49:89-96.
66. Schwendt M, Rocha A, See RE, Pacchioni AM, McGinty JF, Kalivas PW. 2009. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 331:555-562.
67. Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK. 2003. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology 28:1730-1740.
68. Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK. 2005. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization. Psychopharmacology 180:501-512.
69. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Mori N. 2003. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 160:1699-1701.
70. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N. 2006. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63:90-100.
71. Simon SL, Dacey J, Glynn S, Rawson R, Ling W. 2004. The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 27:59-66.
72. Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W. 2002. Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21:61-74.
73. Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED. 1996. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res 738:172-175.
74. Spear LP. 2000. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463.
75. Spear LP. 2004. Adolescent brain development and animal models. Ann NY Acad Sci 1021:23-26.
76. Spiller HA, Ryan ML, Weston RG, Jansen J. 2011. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila) 49:499-505.
77. Swant J, Chirwa S, Stanwood G, Khoshbouei H. 2010. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS One 5:e11382.
78. Swant J, Goodwin JS, North A, Ali AA, Gamble-George J, Chirwa S, Khoshbouei H. 2011. alpha-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. J Biol Chem 286:43933-43943.
79. Tan XJ, Dai YB, Wu WF, Warner M, Gustafsson JA. 2012. Anxiety in liver X receptor beta knockout female mice with loss of glutamic acid decarboxylase in ventromedial prefrontal cortex. Proc Natl Acad Sci USA 109:7493-7498.
80. Thompson AM, Gosnell BA, Wagner JJ. 2002. Enhancement of long-term potentiation in the rat hippocampus following cocaine exposure. Neuropharmacology 42:1039-1042.
81. Thompson AM, Swant J, Gosnell BA, Wagner JJ. 2004. Modulation of long-term potentiation in the rat hippocampus following cocaine self-administration. Neuroscience 127:177-185.
82. van Goethem NP, Rutten K, van der Staay FJ, Jans LA, Akkerman S, Steinbusch HW, Blokland A, van't Klooster J, Prickaerts J. 2012. Object recognition testing: rodent species, strains, housing conditions, and estrous cycle. Behav Brain Res 232:323-334.
83. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J. 2001a. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21:9414-9418.
84. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN. 2001b. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377-382.
85. Volz TJ, Fleckenstein AE, Hanson GR. 2007. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction 102(Suppl 1):44-48.
86. Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL. 2001. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 292:1175-1178.
87. Wallace TL, Gudelsky GA, Vorhees CV. 1999. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. J Neurosci 19:9141-9148.
88. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. 1996. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699-703.